Kingsway Financial Services Inc. — Q3 2022 Form 10-Q
Business context and reporting period. This unaudited quarterly filing covers the three and nine months ended September 30, 2022. Kingsway is a U.S.-focused holding company with three reportable segments: Extended Warranty, Leased Real Estate, and Kingsway Search Xcelerator (Ravix, acquired October 2021). Amounts below are in U.S. dollars; financial statement amounts are in millions unless noted.
Key financial results
| Metric | Q3 2022 | Q3 2021 | Nine months 2022 | Nine months 2021 |
|---|---|---|---|---|
| Total revenue | $26.0 | $21.0 | $79.4 | $65.0 |
| Operating income (loss) | $(3.4) | $(0.1) | $(0.2) | $1.5 |
| Segment operating income* | $4.1 | $2.5 | $12.8 | $9.4 |
| Income from continuing operations | $39.8 | $(0.2) | $34.9 | $0.4 |
| Net income (loss) | $37.3 | $(0.2) | $32.4 | $0.4 |
| Net cash from (used in) operating activities | — | $9.3 | $(8.0) |
*Non-GAAP measure defined by the company as segment revenue less direct segment expenses. It excludes corporate and other items.
- Revenue and segment performance: Q3 revenue increased 24% year over year, with growth from Ravix and Leased Real Estate, partly offset by PWSC’s disposal and mixed trends among warranty businesses. Nine-month revenue rose 22%. Segment operating income was higher in Q3 and year to date; the nine-month Extended Warranty contribution declined year over year.
- Earnings quality and margins: GAAP operating losses were reported in both periods in 2022, despite positive segment operating income. Q3 continuing-operations income included a $37.9 million gain on the PWSC sale and a $13.5 million gain on trust-preferred repurchase options. The resulting net margin is not representative of recurring operations.
- Cash flow: Nine-month operating cash flow was $9.3 million, versus $8.0 million used in 2021. Investing activities provided $33.6 million, primarily reflecting $35.2 million of net cash proceeds from the PWSC disposal. Financing activities used $11.0 million, including bank-loan and note repayments.
- Liquidity: September 30 cash and cash equivalents were $48.6 million, with restricted cash of $13.2 million. Management reported holding-company cash liquidity of $44.6 million, up from $2.2 million at year-end 2021; this excludes restricted cash and other potential sources of liquidity. Total investments were $70.3 million.
- Debt and equity: Debt carrying value was $283.6 million ($304.3 million principal), including $199.6 million of notes payable, $21.8 million of bank loans, and $62.3 million of subordinated debt carried at fair value. Total liabilities were $457.1 million. Shareholders’ equity increased to $43.0 million from $8.3 million at year-end 2021, reflecting reported earnings and the disposal gain.
- Margins: Segment operating income was approximately 15.7% of revenue in Q3 2022 versus 11.9% in Q3 2021. Consolidated operating margin was negative in both periods; the filing does not present a recurring or adjusted consolidated margin.
Material changes, outlook, risks, and unusual items
- On July 29, 2022, Kingsway sold its 80%-owned PWSC subsidiary for a stated base purchase price of $51.2 million, subject to customary adjustments. It recognized a $37.9 million net gain and received $35.2 million of net cash proceeds. The sale was not classified as a discontinued operation. PWSC’s results are included through the sale date.
- In Q3, Kingsway recognized a $13.5 million gain on fair-value changes in options to repurchase trust-preferred debt. The options cover up to approximately $59.7 million of principal and deferred interest; the options’ reported fair value was $15.8 million. The company paid approximately $2.3 million for the options and had not repurchased TruPS by quarter-end.
- Interest payments on $90.5 million principal of trust-preferred debt have been deferred since 2018. Deferred interest was $23.2 million at September 30, 2022. The company may continue deferral through Q3 2023; while deferral continues, it cannot redeem its outstanding preferred shares, with a $5.9 million redemption value. Management says current cash, investments, and expected operating cash flows should cover working-capital and operating needs, including potential preferred redemption and deferred interest, for the next 12 months. This is subject to risks and uncertainties, including COVID-19 effects.
- A $2.5 million liability and discontinued-operations loss were recorded for indemnification of open claims relating to the former Mendota insurance businesses; payment is not due until Q1 2023. The company’s maximum stated obligation is $2.5 million.
- Flower sold its investment properties for $12.2 million on September 29, 2022 and used proceeds to repay its note. Because Kingsway consolidates Flower on a three-month lag, the sale and repayment were not yet reflected in the September 30 balance sheet; the company expected to record them in Q4. A $1.5 million fair-value gain was recorded in Q3 based on the sale price.
- The company acquired CSuite Financial Partners for approximately $8.5 million after quarter-end, on November 1, 2022, using cash on hand; up to $3.6 million of additional earnout payments may be payable if targets are achieved.
- No formal financial guidance is provided. Management cited automotive supply-chain and used-car inventory conditions affecting some warranty businesses, while IWS sales volumes were trending toward pre-COVID levels. The filing identifies no material change to previously disclosed risk factors.
- Goodwill of $61.0 million relates to CMC in Leased Real Estate. Management reported no impairment indication in its Q3 assessment, but stated that estimated fair value is sensitive to discount rates, cash-flow assumptions, appraised values, and sustained increases in interest rates.
- Disclosure controls were concluded to be ineffective because of an unremediated material weakness involving accounting for complex and nonrecurring transactions, specifically adoption and application of ASC 606 revenue guidance. Management described remediation procedures underway.
Most important facts for investors to verify
- How much of reported earnings and cash generation is recurring after excluding the PWSC gain, TruPS-option fair-value gain, and real-estate valuation gain—and what the post-sale impact is on revenue and segment earnings.
- Whether and when the company exercises its TruPS repurchase options, the final purchase price and funding source, and the impact of continuing interest deferrals and accumulated interest on liquidity and preferred-share redemption.
- The status and timing of Mendota claims payments, and any developments in the Aegis indemnity matter, for which exposure was not reasonably determinable and no liability was recorded.
- The Q4 accounting and cash proceeds from the Flower property sale and debt repayment, and the funding and performance terms of the CSuite acquisition and earnout.
- Progress in remediating the ASC 606 material weakness, compliance with debt covenants, and sensitivity of CMC goodwill valuation to rates and operating assumptions.